市場調査レポート
商品コード
1402471

中南米の放射性医薬品セラノスティクス市場の2028年までの予測- 地域別分析- 製品タイプ別、放射性同位元素別、線源別、用途別、適応症別、エンドユーザー別

South & Central America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type, Radioisotope ; Source, Application ; Indication, and End User

出版日: | 発行: The Insight Partners | ページ情報: 英文 145 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
中南米の放射性医薬品セラノスティクス市場の2028年までの予測- 地域別分析- 製品タイプ別、放射性同位元素別、線源別、用途別、適応症別、エンドユーザー別
出版日: 2023年10月26日
発行: The Insight Partners
ページ情報: 英文 145 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の放射性医薬品セラノスティクス市場は、2022年に1億2,948万米ドルと評価され、2028年には2億3,371万米ドルに達すると予測され、2022年から2028年までのCAGRは10.3%と推定されます。

個別化放射性医薬品治療のためのセラノスティックデジタルツインが中南米の放射性医薬品セラノスティクス市場を煽る

放射性医薬品治療(RPT)では、治療を受けるすべての患者に特定の放射性薬剤(Lu-177-PSMAやLu-177-DOTATATEでは200mCiなど)を注射します。しかし、注射によって臓器に送達される線量や吸収される薬剤の質は、顕著なばらつきを示します。腫瘍や正常組織に対する放射性医薬品治療は吸収線量に依存するが、吸収のばらつきをコントロールすることは困難です。しかし、吸収量のばらつきはコントロールが難しいです。投与量を固定すると、患者の治療が不十分となり、線量毒性を引き起こす可能性があります。このような制約を克服するために、薬剤開発プロセスにおいてTDT(Theranostic Digital Twin)を用いることができます。TDTは、放射性薬剤の注入間隔やプロファイル、適切な放射性薬剤の併用療法を決定するとともに、患者間で最適な放射性薬剤の注入部位を調査します。さらに、TDTは適切な計算ツールと組み合わされ、吸収線量の予測モデリングに使用することができます。さらに、TDTは生成される臨床結果の不確実性をゼロにすることを約束するため、患者に真に個別化された治療を提供するための強力なツールとして機能します。このように、個別化された放射性医薬品治療におけるTDTの使用は、放射性医薬品セラノスティクス市場のプレーヤーに有利な機会を提供します。

中南米の放射性医薬品セラノスティクス市場概要

中南米の放射性医薬品セラノスティクス市場は、アルゼンチン、ブラジル、その他中南米に区分されます。この地域の市場成長は、がんと心血管疾患の有病率の増加と、政府による支援計画の存在によるものです。心血管疾患にかかりやすい糖尿病患者の増加が、ブラジルにおける放射性医薬品セラノスティクス市場の成長を促進しています。さらに、ブラジルのヘルスケア支出の拡大が放射性医薬品セラノスティクス市場を後押ししています。

中南米の放射性医薬品セラノスティクス市場の収益と2028年までの予測(金額)

中南米の放射性医薬品セラノスティクス市場セグメンテーション

中南米の放射性医薬品セラノスティクス市場は、製品タイプ、放射性同位体、線源、用途、適応症、エンドユーザー、国によって区分されます。製品タイプ別に見ると、中南米の放射性医薬品セラノスティクス市場はアルファ線放出核種、ベータ線放出核種、陽電子放出断層撮影(PET)トレーサーに区分されます。陽電子放出断層撮影(PET)トレーサーセグメントが2022年に最大の市場シェアを占めました。

放射性医薬品セラノスティクス市場は、放射性タイプ別にテクネチウム-99、ガリウム-68、ヨウ素-131、ヨウ素-123、フッ素-18(18F)、イットリウム90(Y-90)、ルテチウム(Lu)177、銅(Cu)67、銅(Cu)64、その他に区分されます。ルテチウム(Lu)177セグメントが2022年に最大の市場シェアを占めました。

放射性医薬品セラノスティクス市場は、線源に基づいて原子炉とサイクロトロンに二分されます。サイクロトロンセグメントが2022年に大きな市場シェアを占めました。

用途別では、中南米の放射性医薬品セラノスティクス市場は標的治療[Rx]とコンパニオン診断[CDx]に二分されます。2022年には、標的治療[Rx]分野がより大きな市場シェアを占めました。

適応症に基づき、中南米の放射性医薬品セラノスティクス市場は腫瘍学、循環器学、神経学、その他に区分されます。2022年には腫瘍分野が最大の市場シェアを占めました。

エンドユーザー別に見ると、中南米の放射性医薬品セラノスティクス市場は、病院、画像診断センター、学術・研究機関、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、中南米の放射性医薬品セラノスティクス市場は、ブラジル、アルゼンチン、その他南米に区分されます。ブラジルは2022年の中南米の放射性医薬品セラノスティクス市場シェアを独占しました。

Bayer AG、Curium、Telix Pharmaceuticals Ltd.、Siemens Healthineersなどが南米・中米の放射性医薬品セラノスティクス市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 中南米の放射性医薬品セラノスティクス市場:注目点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の放射性医薬品セラノスティクス市場:市場情勢

  • PEST分析
    • 中南米のPEST分析
  • 専門家の見解

第5章 放射性医薬品セラノスティクス市場:主要市場力学

  • 市場促進要因
    • がん罹患率の上昇
    • 心血管疾患治療への応用拡大
  • 市場抑制要因
    • 放射性医薬品セラノスティクスの承認に向けた規制課題
  • 市場機会
    • 個別化放射性医薬品治療のためのセラノスティックデジタルツイン
  • 今後の動向
    • 核医学における放射性医薬品セラノスティクス
  • 影響分析

第6章 放射性医薬品セラノスティクス市場:中南米分析

  • 中南米の放射性医薬品セラノスティクス市場収益と予測分析

第7章 中南米の放射性医薬品セラノスティクス市場:製品タイプ別収益と2028年までの予測

  • 放射性医薬品セラノスティクス市場の収益シェア(2021年・2028年)

第8章 放射性医薬品セラノスティクスの中南米市場分析:放射性同位元素別

  • 放射性医薬品セラノスティクス市場の収益シェア(2021年・2028年)

第9章 中南米の放射性医薬品セラノスティクスの市場分析:線源別

  • 放射性医薬品セラノスティクス市場の収益シェア(2021年・2028年)

第10章 中南米の放射性医薬品セラノスティクス市場の分析:用途別

  • 放射性医薬品セラノスティクス市場の収益シェア(2021年・2028年)

第11章 中南米の放射性医薬品セラノスティクス市場の分析:適応症別

  • 放射性医薬品セラノスティクス市場の収益シェア(2021年・2028年)

第12章 中南米の放射性医薬品セラノスティクス市場の分析:エンドユーザー別

  • 放射性医薬品セラノスティクス市場の収益シェア(2021年・2028年)

第13章 中南米の放射性医薬品セラノスティクス市場 - 収益と2028年までの予測:国別分析

第14章 放射性医薬品セラノスティクス市場:業界情勢

  • 放射性医薬品セラノスティクス市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第15章 企業プロファイル

  • Bayer AG
  • Curium
  • Telix Pharmaceuticals Ltd.
  • Siemens Healthineers AG

第16章 付録

図表

List Of Tables

  • Table 1. Brazil Radiopharmaceutical Theranostics Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Brazil Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Brazil Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Brazil Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Brazil Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Brazil Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Argentina Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Argentina Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Argentina Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Argentina Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Argentina Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Argentina Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market
  • Table 20. Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market
  • Table 21. Glossary of Terms

List Of Figures

  • Figure 1. South & Central America Radiopharmaceutical Theranostics Market Segmentation
  • Figure 2. South & Central America Radiopharmaceutical Theranostics Market, by Country
  • Figure 3. South & Central America Radiopharmaceutical Theranostics Market Overview
  • Figure 4. Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market
  • Figure 5. Brazil Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. South & Central America: PEST Analysis
  • Figure 7. South & Central America Experts' Opinion
  • Figure 8. South & Central America Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints
  • Figure 9. South & Central America Radiopharmaceutical Theranostics Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. South & Central America Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
  • Figure 11. Positron Emission Tomography (PET) Tracers: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Beta Emitters: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Alpha Emitters: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)
  • Figure 15. Technetium-99: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Gallium-68: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Iodine-131: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Iodine-123: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Fluorine-18 (18F): South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Yttrium 90 (Y-90): South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Lutetium (LU) 177: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Copper (CU) 67: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Copper (CU) 64: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. South & Central America Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)
  • Figure 26. Nuclear Reactors: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Cyclotrons: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. South & Central America Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)
  • Figure 29. Targeted Therapeutics (Rx): South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Companion Diagnostics (CDx): South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. South & Central America Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)
  • Figure 32. Oncology: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Neurology: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Cardiology: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Others: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. South & Central America Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)
  • Figure 37. Hospitals: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Diagnostic Imaging Centers: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Academic & Research Institutes: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Others: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. South & Central America: Radiopharmaceutical Theranostics Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 42. South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
  • Figure 43. Brazil Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Argentina Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Rest of South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Growth Strategies in the Radiopharmaceutical Theranostics Market
目次
Product Code: BMIRE00029008

The South & Central America radiopharmaceutical theranostics market was valued at US$ 129.48 million in 2022 and is expected to reach US$ 233.71 million by 2028; it is estimated to register a CAGR of 10.3% from 2022 to 2028.

Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies fuel the South & Central America Radiopharmaceutical Theranostics Market

Radiopharmaceutical therapies (RPTs) involve injecting a particular radioactive drug (such as 200mCi for Lu-177-PSMA and Lu-177-DOTATATE) into all patients undergoing therapy. However, upon injection, the doses delivered to organs and absorbed qualities of drugs show notable variations. Radiopharmaceutical therapies for tumors and normal tissues depend on absorbed doses; however, variations in absorption are difficult to control. A fixed administered dosage results in the undertreatment of patients, possibly leading to cases of dose toxicity. Theranostic digital twins (TDTs) can be employed in the drug development process to overcome such limitations. The TDTs investigate optimal injected radioactive drugs among patients at the sites of injection, along with determining injection intervals and profiles, and suitable combinational radiopharmaceutical therapies. Additionally, TDTs coupled with appropriate computational tools can be used in predictive absorbed radiation dose modeling. Further, TDTs promise zero uncertainties in the clinical results generated, thus acting as a powerful tool for offering truly personalized treatments to patients. Thus, the use of TDTs in personalized radiopharmaceutical therapies provides lucrative opportunities for radiopharmaceutical theranostics market players.

South & Central America Radiopharmaceutical Theranostics Market Overview

The South & Central America radiopharmaceutical theranostics market is segmented into the Argentina, Brazil, and the rest of South & Central America. The market growth in this region is due to the increasing prevalence of cancer and cardiovascular diseases, and presence of supportive government plans. Growing diabetes who are prone to cardiovascular disease is promoting the growth of radiopharmaceutical theranostics market in Brazil. Further, expanding healthcare expenditure in Brazil is boosting the radiopharmaceutical theranostics market.

South & Central America Radiopharmaceutical Theranostics Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Radiopharmaceutical Theranostics Market Segmentation

The South & Central America radiopharmaceutical theranostics market is segmented based on product type, radioisotype, source, application, indication, end user, and country. Based on product type, the South & Central America radiopharmaceutical theranostics market is segmented into alpha emitters, beta emitters, and Positron Emission Tomography (PET) tracers. The Positron Emission Tomography (PET) tracers segment held the largest market share in 2022.

Based on radioisotype, the South & Central America radiopharmaceutical theranostics market is segmented into technetium-99, gallium-68, iodine-131, iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and others. The Lutetium (Lu) 177 segment held the largest market share in 2022.

Based on source, the South & Central America radiopharmaceutical theranostics market is bifurcated into nuclear reactors and cyclotrons. The cyclotrons segment held a larger market share in 2022.

Based on application, the South & Central America radiopharmaceutical theranostics market is bifurcated into targeted therapeutic [Rx] and Companion Diagnostic [CDx]. The targeted therapeutic [Rx] segment held a larger market share in 2022.

Based on indication, the South & Central America radiopharmaceutical theranostics market is segmented into oncology, cardiology, neurology, and others. The oncology segment held the largest market share in 2022.

Based on end user, the South & Central America radiopharmaceutical theranostics market is segmented into hospitals, diagnostic imaging centers, academic and research institutes, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America radiopharmaceutical theranostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America radiopharmaceutical theranostics market share in 2022.

Bayer AG; Curium; Telix Pharmaceuticals Ltd.; and Siemens Healthineers are some of the leading companies operating in the South & Central America radiopharmaceutical theranostics market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central Americaradiopharmaceutical theranostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central Americaradiopharmaceutical theranostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central Americaradiopharmaceutical theranostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Radiopharmaceutical Theranostics Market - by Product Type
    • 1.3.2 South & Central America Radiopharmaceutical Theranostics Market - by Radioisotope
    • 1.3.3 South & Central America Radiopharmaceutical Theranostics Market - by Source
    • 1.3.4 South & Central America Radiopharmaceutical Theranostics Market - by Application
    • 1.3.5 South & Central America Radiopharmaceutical Theranostics Market - by Indication
    • 1.3.6 South & Central America Radiopharmaceutical Theranostics Market - by End User
    • 1.3.7 South & Central America Radiopharmaceutical Theranostics Market - by Country

2. South & Central America Radiopharmaceutical Theranostics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Radiopharmaceutical Theranostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis
  • 4.3 Expert's Opinion

5. South & Central America Radiopharmaceutical Theranostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidence of Cancer
    • 5.1.2 Rising Application in Treatment of Cardiovascular Disorders
  • 5.2 Market Restraints
    • 5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
  • 5.3 Market Opportunities
    • 5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
  • 5.4 Future Trends
    • 5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
  • 5.5 Impact Analysis

6. Radiopharmaceutical Theranostics Market - South & Central America Analysis

  • 6.1 South & Central America Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis

7. South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - by Product Type

  • 7.1 Overview
  • 7.2 Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
    • 7.2.1 Positron Emission Tomography (PET) Tracers
      • 7.2.1.1 Overview
      • 7.2.1.2 Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.2.2 Beta Emitters
      • 7.2.2.1 Overview
      • 7.2.2.2 Beta Emitters: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.2.3 Alpha Emitters
      • 7.2.3.1 Overview
      • 7.2.3.2 Alpha Emitters: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Radiopharmaceutical Theranostics Market Analysis - by Radioisotope

  • 8.1 Overview
  • 8.2 Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)
    • 8.2.1 Technetium-99
      • 8.2.1.1 Overview
      • 8.2.1.2 Technetium-99: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.2 Gallium-68
      • 8.2.2.1 Overview
      • 8.2.2.2 Gallium-68: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.3 Iodine-131
      • 8.2.3.1 Overview
      • 8.2.3.2 Iodine-131: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.4 Iodine-123
      • 8.2.4.1 Overview
      • 8.2.4.2 Iodine-123: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.5 Fluorine-18 (18F)
      • 8.2.5.1 Overview
      • 8.2.5.2 Fluorine-18 (18F): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.6 Yttrium 90 (Y-90)
      • 8.2.6.1 Overview
      • 8.2.6.2 Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.7 Lutetium (LU) 177
      • 8.2.7.1 Overview
      • 8.2.7.2 Lutetium (LU) 177: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.8 Copper (CU) 67
      • 8.2.8.1 Overview
      • 8.2.8.2 Copper (CU) 67: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.9 Copper (CU) 64
      • 8.2.9.1 Overview
      • 8.2.9.2 Copper (CU) 64: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.10 Others
      • 8.2.10.1 Overview
      • 8.2.10.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Radiopharmaceutical Theranostics Market Analysis - by Source

  • 9.1 Overview
  • 9.2 Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)
    • 9.2.1 Nuclear Reactors
      • 9.2.1.1 Overview
      • 9.2.1.2 Nuclear Reactors: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.2 Cyclotrons
      • 9.2.2.1 Overview
      • 9.2.2.2 Cyclotrons: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Radiopharmaceutical Theranostics Market Analysis - by Application

  • 10.1 Overview
  • 10.2 Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)
    • 10.2.1 Targeted Therapeutic (Rx)
      • 10.2.1.1 Overview
      • 10.2.1.2 Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.2 Companion Diagnostic (CDx)
      • 10.2.2.1 Overview
      • 10.2.2.2 Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

11. South & Central America Radiopharmaceutical Theranostics Market Analysis - by Indication

  • 11.1 Overview
  • 11.2 Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)
    • 11.2.1 Oncology
      • 11.2.1.1 Overview
      • 11.2.1.2 Oncology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.2 Neurology
      • 11.2.2.1 Overview
      • 11.2.2.2 Neurology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.3 Cardiology
      • 11.2.3.1 Overview
      • 11.2.3.2 Cardiology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.4 Others
      • 11.2.4.1 Overview
      • 11.2.4.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

12. South & Central America Radiopharmaceutical Theranostics Market Analysis - by End User

  • 12.1 Overview
  • 12.2 Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)
    • 12.2.1 Hospitals
      • 12.2.1.1 Overview
      • 12.2.1.2 Hospitals: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.2 Diagnostic Imaging Centers
      • 12.2.2.1 Overview
      • 12.2.2.2 Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.3 Academic & Research Institutes
      • 12.2.3.1 Overview
      • 12.2.3.2 Academic & Research Institutes: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.4 Others
      • 12.2.4.1 Overview
      • 12.2.4.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

13. South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - by Country Analysis

  • 13.1 South & Central America Radiopharmaceutical Theranostics Market
    • 13.1.1 Overview
    • 13.1.2 South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
      • 13.1.2.1 Brazil: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.1 Overview
        • 13.1.2.1.2 Brazil Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.3 Brazil Radiopharmaceutical Theranostics Market, by Product type, 2019-2028 (US$ Million)
        • 13.1.2.1.4 Brazil Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
        • 13.1.2.1.5 Brazil Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
        • 13.1.2.1.6 Brazil Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
        • 13.1.2.1.7 Brazil Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
        • 13.1.2.1.8 Brazil Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
      • 13.1.2.2 Argentina: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.1 Overview
        • 13.1.2.2.2 Argentina Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.3 Argentina Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
        • 13.1.2.2.4 Argentina Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
        • 13.1.2.2.5 Argentina Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
        • 13.1.2.2.6 Argentina Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
        • 13.1.2.2.7 Argentina Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
        • 13.1.2.2.8 Argentina Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
      • 13.1.2.3 Rest of South & Central America: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.1 Overview
        • 13.1.2.3.2 Rest of South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.3 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
        • 13.1.2.3.4 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
        • 13.1.2.3.5 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
        • 13.1.2.3.6 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
        • 13.1.2.3.7 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
        • 13.1.2.3.8 Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)

14. Radiopharmaceutical Theranostics Market - Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Radiopharmaceutical Theranostics Market
  • 14.3 Inorganic Growth Strategies
    • 14.3.1 Overview
  • 14.4 Organic Growth Strategies
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Bayer AG
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Curium
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Telix Pharmaceuticals Ltd.
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Siemens Healthineers AG
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms